Trial

TMC207-TBC211: A Phase II, open-label, multicenter single arm study to evaluate the pharmacokinetics, safety, tolerability and anti-mycobacterial activity of TMC207 in combination with a standard regi

Study Director
Start Date
0 / 0
Trial Phase
Trial Status
study in development
Current Enrollment
Target Enrollment
Overview
Compound Associations